IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

Thousands of members of the LGBTQI+ and sex worker communities can now donate plasma in Australia without having to wait ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history' ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...